Indices pare gains; pharma shares in demand

Image
Capital Market
Last Updated : Dec 06 2019 | 10:50 AM IST

Key indices pared gains in morning trade. At 10:21 IST, the barometer index, the S&P BSE Sensex, was up 34.93 points or 0.09% at 40,814.52. The Nifty 50 index was up 6.80 points or 0.06% at 12,025.20.

The S&P BSE Mid-Cap index was down 0.04%. The S&P BSE Small-Cap index was trading almost flat.

The market breadth, indicating the overall health of the market, was positive. On the BSE, 873 shares rose and 855 shares fell. A total of 97 shares were unchanged. In Nifty 50 index, 25 stocks advanced while 25 stocks declined.

Buzzing Index:

The Nifty Pharma index rose 1.15% to 8,144.55, reversing losses acquired in the previous session.

Glenmark Pharmaceuticals (up 2.56%), Dr Reddy's Laboratories (up 1.98%), Sun Pharmaceutical Industries (up 1.41%), Strides Shasun (up 1.22%), Cipla (up 0.87%), Aurobindo Pharma (up 0.69%), GlaxoSmithKline Pharmaceuticals (up 0.6%), IPCA Laboratories (up 0.57%), Divi's Laboratories (up 0.53%), Wockhardt (up 0.26%), Cadila Healthcare (up 0.19%) and Piramal Enterprises (up 0.11%) advanced.

Alkem Laboratories (down 0.49%) and Lupin (down 0.19%) declined.

Stocks in Spotlight:

RBL Bank slipped 0.12% to Rs 364.95. The private sector bank said the qualified institutional placement (QIP) of equity shares which opened on Monday, 2 December 2019, ended yesterday, on 5 December 2019. It has approved allocation of 5.77 crore equity shares at an issue price of Rs. 351 per share.

Kesoram Industries rose 3.05% to Rs 62.05, rising for second consecutive session. The stocks has risen 9.53% to its current market price from a recent closing high of Rs 56.65 on 4 December 2019.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 06 2019 | 10:23 AM IST

Next Story